Search Results for: covid-19
Articles
EyePoint Pharmaceuticals Receives $9.5 Million From Ocumension Therapeutics Under Expanded License Agreements August 20, 2020
EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics recently announced the expansion of their exclusive license agreements for the development and commercialization of….
Humanetics Corporation & Pharmaceutics International, Inc. Announce Partnership August 20, 2020
Humanetics Corporation and Pharmaceutics International, Inc. (Pii) will work together to support a clinical trial of BIO 300 in COVID-19 patients…..
Organicell Provides Phase 1/2 Clinical Trial Update August 19, 2020
Organicell Regenerative Medicine, Inc. recently announced it has partnered with Alternative Research Associates, LLC and Larkin Hospital in Miami, FL,...TFF Pharmaceuticals Enters into Worldwide Licensing Agreement With UNION Therapeutics August 19, 2020
TFF Pharmaceuticals, Inc. recently announced it has entered into a worldwide exclusive licensing agreement with UNION therapeutics A/S (UNION) for...Immunic, Inc. Reports Positive Top-line Data From Phase 2 EMPhASIS Trial August 7, 2020
Immunic, Inc. recently announced positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the company’s selective...Corbus Pharmaceuticals Completes Enrollment in Phase 3 Study August 7, 2020
Corbus Pharmaceuticals Holdings, Inc. recently announced the completion of subject enrollment in DETERMINE, a Phase 3 study assessing the efficacy...Don’t Miss RNA Medicine in a Pandemic Symposium on July 23! July 8, 2020
Join us as we are hosting an RNA Symposium bringing together leading experts in RNA medicine, delivery, technology development, and solutions for manufacturing to present and discuss…
Timber Pharmaceuticals Announces All CONTROL Study Sites Open & Enrolling Patients With Moderate-to-Severe Congenital Ichthyosis July 1, 2020
Timber Pharmaceuticals, Inc. recently announced that all 11 sites across the US and Australia participating in the Phase 2b CONTROL study evaluating TMB-001 (topical isotretinoin) are now….
2020 Respiratory Drug Development eBook – Inhaled Medications for Treating Unconventional Respiratory Diseases June 30, 2020
This second annual Drug Development & Delivery Respiratory eBook focuses on a few companies that are taking inhalation devices to a new level in drug delivery.
Ajinomoto Bio-Pharma Services Introduces AJILITY Fast-Track Platform for Drug Product Manufacturing June 30, 2020
Ajinomoto Bio-Pharma Services recently announce the launch of AJILITY, a flexible and agile drug product manufacturing platform, designed to advance….
Bormioli Pharma Invests in Type I Glass Vial Production for Injectable Medicines & Vaccines June 29, 2020
The global, Covid-19 pandemic emergency has not weakened Bormioli Pharma's determination to keep on investing and supporting its customers. After...Mateon & GMP Completed Research & Service Agreement June 24, 2020
Mateon Therapeutics, Inc. recently announced that both Golden Mountain Partners (GMP) and Mateon have fulfilled all the obligations under the Research and Services Agreement entered on….
Bionic Sight Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Blindness June 17, 2020
Bionic Sight, LLC recently announced it has dosed the first patient in the company’s Phase 1/2 clinical trial of BS01, an optogenetic gene therapy for patients with….
Arch Biopartners Announces FDA Acknowledgement of its IND Application June 17, 2020
Arch Biopartners Inc. recently announced the US FDA has received and acknowledged the Investigational New Drug (IND) Application for its...Phathom Pharmaceuticals Provides Clinical Trial Status Update June 17, 2020
Phathom Pharmaceuticals, Inc. recently announced it has randomized the first new patients in each of its two Phase 3 clinical...Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial June 10, 2020
Precision BioSciences, Inc. recently announced that the first patient has been dosed in a Phase 1/2a clinical trial of PBCAR269A,...Arch Biopartners Submits IND Application to the FDA for Metablok (LSALT Peptide) June 10, 2020
Arch Biopartners Inc. recently announced it has submitted an Investigational New Drug (IND) Application to the US FDA for its...SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: Specialized Capabilities for Small & Large Molecules June 4, 2020
Contributor Cindy H. Dubin interviews key players in the CDMO market who present case studies about how they are helping pharmaceutical and biopharma companies overcome a variety of formulation and manufacturing challenges.
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement June 2, 2020
CordenPharma recently announced the signing of an amendment to their existing manufacturing agreement with Moderna, Inc., a clinical stage biotechnology...Taconic Biosciences Launches Rapid Restart Program May 19, 2020
Taconic Biosciences, a global leader in providing drug discovery animal model solutions, recently announced the successful implementation of its Rapid Restart program….
